Ibogaine Treatment centre

What Ibogaine Treatment centre does

Ibogaine Treatment Centre (also operating as Iboga Root Sanctuary) is a private, for-profit addiction and mental-health treatment facility operating under parent Tabula Rasa Retreat. The clinical operation is based in rural Alentejo, Portugal — approximately two hours from Lisbon — with an administrative office in London (250 York Road) and dedicated phone lines serving the UK, Portugal, and the United States. The centre delivers medically supervised ibogaine therapy derived from the Tabernanthe Iboga shrub, offering three extraction tiers: Total Alkaloid (TA), Purified Total Alkaloid (PTA at 96% ibogaine concentration), and Ibogaine Hydrochloride (HCL). Programs are sold as 6-day (€6,621.60 incl. VAT) and 12-day (€13,243.20 incl. VAT) all-inclusive packages, with optional VIP protocols and whole-center buyouts for discretion.

The core therapeutic claim rests on ibogaine's pharmacology — interaction with serotonin, dopamine, and glutamate systems, stimulation of Brain-Derived Neurotrophic Factor (BDNF), and a proposed "neural pathway reset" restoring dopamine and serotonin baselines disrupted by addiction. The facility offers adjunct holistic modalities (mindfulness, equine-assisted therapy, breathwork, Kundalini yoga, drumming, light therapy, medicinal cacao, Kambo), plus a separately launched 5-day psilocybin retreat (Elemental Self RE:Treat) co-developed with external practitioners. Treatment is supported by ACLS-trained nursing staff, 24-hour monitoring, ECG/pulse oximetry during sessions, and a hospital 20 km away.

The go-to-market is direct-to-consumer and sales-led: 24/7 treatment consultants, online application forms, Skype pre-treatment counselling, and a multi-channel content-marketing engine spanning blog, SEO, Instagram, Facebook, Twitter, Pinterest, and podcast/video content. Patient segments include individuals with opioid, cocaine, alcohol, benzodiazepine, methamphetamine, nicotine, and behavioural addictions; those with PTSD, depression, anhedonia, and trauma; patients with neurodegenerative conditions (Parkinson's) and autoimmune disease (MS); and personal-development clients seeking psycho-spiritual growth. Pricing is one-time, pay-as-you-go with no disclosed insurance or institutional reimbursement pathway.

Name

Ibogaine Treatment centre

Legal name

Ibogaine Treatment UK

Website

https://ibogainetreatment.co.uk

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Ibogaine Treatment Centre is a private Portugal-based facility (subsidiary of Tabula Rasa Retreat) that delivers medically supervised ibogaine therapy programs for individuals with substance addictions, PTSD, depression, and related mental-health conditions, selling 6-day and 12-day all-inclusive packages direct-to-consumers globally.

Ownership category

akta.pro rank

Product category

Addiction Treatment Services

NAICS

Outpatient Mental Health and Substance Abuse Centers (621420)

SIC

Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Outpatient Substance Use Treatment Programs (IOP/PHP/OP) (HLAFACAF)

akta.pro secondary industry

Outpatient Substance Use Disorder (SUD) Treatment Programs (HLAFABAD)

Keywords

• Ibogaine treatment
• Addiction recovery therapy
• Psychedelic-assisted therapy
• Substance abuse treatment
• Residential detox programmes

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Ibogaine Treatment Programs: One-time treatment fees for all-inclusive ibogaine therapy programs. Programs include preparation, ibogaine ceremony, medical supervision, accommodation, meals, and optional aftercare. 6-day program at €6,621.60 and 12-day program at €13,243.20.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels7 records

Core offering

The Ibogaine Treatment Centre delivers medically supervised ibogaine-based residential treatment programmes for addiction and mental health conditions at its facility in Alentejo, Portugal. Programmes are sold as all-inclusive fixed-duration packages (6-day and 12-day), and the centre also offers complementary Kambo and psilocybin retreat services. The business operates as part of the Tabula Rasa Retreat group with administrative support from London.

Product overview

Ibogaine Treatment Centre (also known as Iboga Root Sanctuary and operating as a subsidiary of Tabula Rasa Retreat) offers a comprehensive portfolio of addiction treatment and holistic wellness services centered around ibogaine therapy derived from the African Tabernanthe Iboga shrub. The core offerings consist of 6-Day and 12-Day All-Inclusive Programmes that provide medically supervised ibogaine treatments for addiction (opioids, cocaine, alcohol, methamphetamines, benzodiazepines, nicotine) and mental health conditions (PTSD, depression, complex PTSD, anhedonia). These are complemented by holistic therapy modules including mindfulness, equine therapy, breathwork, Kundalini yoga, and Kambo treatment. The centre also offers psilocybin/sacred mushroom retreats as an additional psychedelic therapy option. All treatments are conducted in a luxury facility in rural Alentejo, Portugal, with 24/7 medical supervision by ACLS-trained staff.

Differentiator

Problem solved

Functional benefit

Products and services

• 6-Day All-Inclusive Ibogaine Programme A six-day all-inclusive residential programme delivering medically supervised ibogaine treatment for addiction and mental health conditions, priced at €6,621.60 per participant.
• 12-Day All-Inclusive Ibogaine Programme A twelve-day all-inclusive residential programme delivering medically supervised ibogaine treatment with extended therapeutic support, priced at €13,243.20 per participant.
• Kambo Treatment Standalone Kambo ceremonial therapy service offered at the centre as a complementary modality to its ibogaine programmes.
• Sacred Mushroom / Psilocybin Retreat Residential psilocybin retreat offering distinct from the ibogaine programme, positioned for mental health and personal development use cases.

Quantifiable outcome

• Significant reduction in PTSD symptoms within 24 hours of treatment
• +2 more outcomes

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Alvaro de Ferranti (Tabula Rasa Retreat Co-owner/Co-founder)coreStrategic or Co-development PartnerCo-owner and co-founder of Tabula Rasa Retreat, bringing expertise in entheogenic therapies and experience overseeing one of the world's premier ibogaine treatment centers. Focus on safe treatment, holistic therapy, and committed aftercare. Collaborated on sacred mushroom Elemental Self RE:Treat retreat.
• Jessica Grotfeldt (Luz Eterna Retreats)coreStrategic or Co-development PartnerFounder of Luz Eterna Retreats, renowned expert in psilocybin therapy with over 20 years of experience as psychedelic guide and facilitator. Work featured in Vice Magazine and Michelle Janikian's book 'Your Psilocybin Companion'. Collaborated on Elemental Self RE:Treat sacred mushroom retreat.
• Clare S. Wilkins (Pangea Biomedics)minorStrategic or Co-development PartnerFounder of Pangea Biomedics, active board member of Global Ibogaine Therapy Alliance (GITA) since 2010. Collaborated with MAPS on seminal Mexico study. Has facilitated over 700 ibogaine treatments. Currently collaborating with ICEERS on clinical trials for ibogaine-assisted methadone detox.
• Global Ibogaine Therapy Alliance (GITA)minorStrategic or Co-development PartnerInternational organization for ibogaine therapy advocacy and standards. Board membership connection through Clare S. Wilkins.
• ICEERS (International Center for Ethnobotanical Education, Research and Service)minorStrategic or Co-development PartnerOrganization advancing clinical trials and research for ibogaine-assisted detox. Currently developing clinical trials for ibogaine-assisted detox to successfully get people off methadone.
• MAPS (Multidisciplinary Association for Psychedelic Studies)minorStrategic or Co-development PartnerLeading psychedelic research organization. Collaboration on Mexico study for ibogaine research.

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• Kusnacht Practice: Switzerland-based ultra-premium addiction and mental health treatment facility offering residential programs to a self-pay international clientele; competes for the same high-end addiction-treatment patient segment though without ibogaine specialization.
• Compass Pathways: Public clinical-stage psychedelic therapy company developing COMP360 psilocybin for treatment-resistant depression; represents the regulated pharmaceutical direction that could eventually compete for the same patient indications.

Direct peers

• Pangea Biomedics: Mexico-based ibogaine treatment center founded by Clare S. Wilkins (named partner of Ibogaine Treatment Centre); offers very similar medically supervised ibogaine protocols and shares an affiliated practitioner network.
• Clear Sky Recovery: Cancun-based ibogaine clinic offering medically supervised ibogaine detox programs for opioid and stimulant addiction; competes directly with Ibogaine Treatment Centre for the same medical-tourism patient segment.
• Beond Ibogaine: Mexico-based luxury ibogaine treatment provider offering medically supervised ibogaine therapy for addiction and mental health; directly competes for the same global, self-pay clientele as Ibogaine Treatment Centre.
• Eleusinia Retreat: Portugal-based psilocybin and psychedelic retreat operator in the same Alentejo/Portugal region; competes for international self-pay psychedelic-therapy guests considering alternative modalities.
• Crossroads Treatment Center: Antigua-based ibogaine clinic providing medically supervised ibogaine detox for opioid addiction; directly comparable service model and self-pay, internationally-marketed offering.
• The Holistic Sanctuary: Mexico-based luxury alternative addiction treatment center using ibogaine and holistic protocols; comparable premium pricing model and self-pay medical-tourism positioning.

Emerging players

• Inner Trek: Oregon-based psilocybin service center offering supervised psilocybin experiences in a regulated state framework; adjacent psychedelic therapy competitor whose modality overlaps with the centre's planned psilocybin retreat offering.

Others

• Tabula Rasa Retreat: Parent organisation of Ibogaine Treatment Centre; operates broader psychedelic and wellness retreat offerings in Portugal and provides shared operational and reputational infrastructure.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/TabulaRasaR
• Facebookfacebook.com/tabularasaretreat
• Instagraminstagram.com/tabularasaretreat
• Pinterestpinterest.co.uk/tabularasar

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ibogaine Treatment centre